HC Wainwright & Co. Reiterates Milestone Pharmaceuticals (MIST) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 15, 2023, HC Wainwright & Co. reiterated coverage of Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy recommendation.
